West Pharmaceutical Services | WST - Equity Capital And Reserves


West Pharmaceutical Services reported $3.18B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Align Technology USD 3.96B 44.68M Sep/2025
Avanos Medical USD 778.2M 200K Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Cerus USD 61.46M 6.04M Sep/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Cooper Companies USD 8.35B 64.9M Jun/2025
Dentsply International USD 1.48B 482M Sep/2025
Haemonetics USD 911.45M 62.28M Dec/2025
ICU Medical USD 2.12B 3.42M Dec/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 1.09M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
J&J USD 78.47B 0 Sep/2025
Medtronic USD 48.86B 964M Sep/2025
Merit Medical Systems USD 1.58B 54.9M Dec/2025
Neogen USD 2.1B 14.16M Sep/2025
OraSure Technologies USD 361.98M 18.74M Sep/2025
Quidel USD 1.92B 115.9M Dec/2025
Repligen USD 2.11B 1.66B Dec/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
Solventum Corp USD 4.99B 1.34B Sep/2025
STAAR Surgical USD 353.78M 17.21M Sep/2025
Terumo JPY 1.52T 84.79B Dec/2025
Utah Medical Products USD 118.25M 719K Sep/2025
West Pharmaceutical Services USD 3.18B 124.5M Dec/2025